-
Something wrong with this record ?
Results of retrospective classification of thyroid FNAs according to the Bethesda system: would this have improved accuracy
L. Srbova, F. Gabalec, A. Ryska, J. Cap,
Language English Country England, Great Britain
Document type Journal Article
PubMed
25077794
DOI
10.1111/cyt.12171
Knihovny.cz E-resources
- MeSH
- Cytodiagnosis methods MeSH
- Humans MeSH
- Thyroid Neoplasms pathology MeSH
- Retrospective Studies MeSH
- Thyroid Gland pathology MeSH
- Biopsy, Fine-Needle methods MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
OBJECTIVES: To retrospectively reclassify the results of fine needle aspiration (FNA) cytology at our institution according to the Bethesda system for reporting thyroid cytopathology (TBSRTC), and to determine whether the introduction of the new classification system would have influenced the diagnostic accuracy compared with our existing system in which suspicious/indeterminate categories (categories III-IV) are managed according to clinical findings and cytopathologists' recommendations. METHODS: FNAs performed under ultrasound guidance between 2001 and 2012, and subsequently verified by histology or repeat FNA and follow-up, were reviewed and retrospectively reclassified according to TBSRTC. RESULTS: Among a total of 1310 histologically verified FNAs, the positive predictive values (%) for malignancy and neoplasia (carcinoma + follicular adenomas) for category I-VI according to the TBSRTC were 5.7/11.3, 2.6/5.5, 14.4/34.2, 23.6/55.0, 57.0/64.5 and 92.2/94.2, respectively. Although all the categories predict malignancy closely, the difference in malignancy rate between categories III and IV was not statistically significant; however, the difference in total neoplasia rate reached statistical significance. When patients with cytological and clinical follow-up were included, the malignancy rated dropped in category I to 2.4%, whereas, in category III, it remained at 13%. Repeat FNA instead of direct surgery spared half of the patients from surgery. The cytopathologists' recommendations for histological verification in category III were associated with an insignificant increase in malignancy rate, but the total neoplasia rate reached 57.5%. CONCLUSIONS: At our institution, the application of the TBSRTC did not improve the diagnostic accuracy for the detection of malignancy compared with current practice. In selected cases with cytological results falling into category III (according to clinical data and cytopathologists' opinions), direct lobectomy seems to be justified.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16021078
- 003
- CZ-PrNML
- 005
- 20160725114001.0
- 007
- ta
- 008
- 160722s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/cyt.12171 $2 doi
- 024 7_
- $a 10.1111/cyt.12171 $2 doi
- 035 __
- $a (PubMed)25077794
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Srbova, L $u Department of Clinical Endocrinology, The Institute of Endocrinology, Prague, Czech Republic.
- 245 10
- $a Results of retrospective classification of thyroid FNAs according to the Bethesda system: would this have improved accuracy / $c L. Srbova, F. Gabalec, A. Ryska, J. Cap,
- 520 9_
- $a OBJECTIVES: To retrospectively reclassify the results of fine needle aspiration (FNA) cytology at our institution according to the Bethesda system for reporting thyroid cytopathology (TBSRTC), and to determine whether the introduction of the new classification system would have influenced the diagnostic accuracy compared with our existing system in which suspicious/indeterminate categories (categories III-IV) are managed according to clinical findings and cytopathologists' recommendations. METHODS: FNAs performed under ultrasound guidance between 2001 and 2012, and subsequently verified by histology or repeat FNA and follow-up, were reviewed and retrospectively reclassified according to TBSRTC. RESULTS: Among a total of 1310 histologically verified FNAs, the positive predictive values (%) for malignancy and neoplasia (carcinoma + follicular adenomas) for category I-VI according to the TBSRTC were 5.7/11.3, 2.6/5.5, 14.4/34.2, 23.6/55.0, 57.0/64.5 and 92.2/94.2, respectively. Although all the categories predict malignancy closely, the difference in malignancy rate between categories III and IV was not statistically significant; however, the difference in total neoplasia rate reached statistical significance. When patients with cytological and clinical follow-up were included, the malignancy rated dropped in category I to 2.4%, whereas, in category III, it remained at 13%. Repeat FNA instead of direct surgery spared half of the patients from surgery. The cytopathologists' recommendations for histological verification in category III were associated with an insignificant increase in malignancy rate, but the total neoplasia rate reached 57.5%. CONCLUSIONS: At our institution, the application of the TBSRTC did not improve the diagnostic accuracy for the detection of malignancy compared with current practice. In selected cases with cytological results falling into category III (according to clinical data and cytopathologists' opinions), direct lobectomy seems to be justified.
- 650 _2
- $a tenkojehlová biopsie $x metody $7 D044963
- 650 _2
- $a cytodiagnostika $x metody $7 D003581
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a štítná žláza $x patologie $7 D013961
- 650 _2
- $a nádory štítné žlázy $x patologie $7 D013964
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gabalec, F $u 4th Dept. of Internal Medicine, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic.
- 700 1_
- $a Ryska, A $u Fingerland's Department of Pathology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic.
- 700 1_
- $a Cap, J $u 4th Dept. of Internal Medicine, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic.
- 773 0_
- $w MED00009532 $t Cytopathology official journal of the British Society for Clinical Cytology $x 1365-2303 $g Roč. 26, č. 4 (2015), s. 231-7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25077794 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20160725114219 $b ABA008
- 999 __
- $a ok $b bmc $g 1155748 $s 945606
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 26 $c 4 $d 231-7 $e 20140730 $i 1365-2303 $m Cytopathology $n Cytopathology $x MED00009532
- LZP __
- $a Pubmed-20160722